Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0001193125-26-209884

See Remarks sold 25,240 shares at $2.51 ($63,352)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rajavelu Esther See Remarks 2026-05-04 Sale −25,240 $2.51 $63,352 986,851 D
Open-market sales · 25,240 sh · avg $2.51 · $63,352
Loading xslF345X06/ownership.xml…